PO40 Hyperfiltration Syndrome as a Cause of Low Anti-Xa Activity Levels during Enoxaparin Treatment in a Critically Ill Patient

M. Martinuzzo, M. López, C. Berger, L. Llera, M. Huber, P. Verónica

Research and Practice in Thrombosis and Haemostasis(2023)

引用 0|浏览6
暂无评分
关键词
enoxaparin treatment,critically ill patient
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要